Btim »

Halozyme Therapeutics shares owned by Btim

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Btim from 13F filings

Historical chart of Btim investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Btim consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Btim

Quarter filed Position value Share count Share price at filing
2024-06-30 $23M 443k 52.36

More positions owned by Btim

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-a Common Stock (GOOGL)
Alphabet Inc-cl C Common Stock (GOOG)
Jpmorgan Chase & Co Common Stock (JPM)
Aptargroup Common Stock (ATR)
Donaldson Common Stock (DCI)
Accenture Plc-cl A Common Stock (ACN)
Visa Common Stock (V)
Waters Corp Common Stock (WAT)
United Health Group Common Stock (UNH)
Johnson & Johnson Common Stock (JNJ)
Costco Wholesale Corp Common Stock (COST)
Jones Lang Lasalle Common Stock (JLL)
Applied Materials Common Stock (AMAT)

View all positions for Btim

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Artisan Partners Limited Partnership
Alliancebernstein
Macquarie Group
Jpmorgan Chase & Co
Geode Capital Management
TD Asset Management
Invesco
Jennifer Ranahan
Arrowpoint Asset Management
Dimensional Fund Advisors
Bank of America Corporation

View all funds holding Halozyme Therapeutics